MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
Top Cited Papers
Open Access
- 1 July 2017
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 23 (7) , 1079-1084
- https://doi.org/10.3201/eid2307.170310
Abstract
MERS-CoV Antibody Responses, South KoreaKeywords
This publication has 17 references indexed in Scilit:
- Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012–2015Emerging Infectious Diseases, 2017
- Persistence of Antibodies against Middle East Respiratory Syndrome CoronavirusEmerging Infectious Diseases, 2016
- Viral Load Kinetics of MERS Coronavirus InfectionNew England Journal of Medicine, 2016
- Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi ArabiaEmerging Infectious Diseases, 2016
- Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus InfectionJournal of Korean Medical Science, 2016
- Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South KoreaEmerging Infectious Diseases, 2015
- Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus InfectionClinical Infectious Diseases, 2015
- Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015Osong Public Health and Research Perspectives, 2015
- Geographic Distribution of MERS Coronavirus among Dromedary Camels, AfricaEmerging Infectious Diseases, 2014
- Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013Eurosurveillance, 2013